$MESO· SEC filing ·

MESO Reports $10.2M Q1 Revenue, $0.02 EPS, +15% YoY, Announces FDA IND Clearance for Ryoncil® in DMD, 76-Patient Registrational Trial, Partners PPMD

Mesoblast Limited American Depositary Shares · Now $14.86

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS